Repligen Corp. (RGEN)

162.02 +0.33 (+0.20%) USD  |  NASDAQ  |  Jan 16, 16:00
162.09 +0.07 (+0.04%) After-Hours: 20:00
More

Repligen Total Long Term Liabilities (Quarterly)

Total Long Term Liabilities (Quarterly) Chart

View Total Long Term Liabilities (Quarterly) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Liabilities (Quarterly) Range, Past 5 Years

View Total Long Term Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Liabilities (Quarterly) Benchmarks

View Total Long Term Liabilities (Quarterly) Benchmarks
Start Trial
Enovis Corp. --
Perspective Therapeutics, Inc. Upgrade
InfuSystem Holdings, Inc. --
Xtant Medical Holdings, Inc. --
VolitionRX Ltd. --